Twitter  |    LinkedIn

Benchside Dispatches: An interview with Masayuki Amagai, MD, PhD

Now Viewing Articles

Advancing Innovation in Dermatology is pleased to make available our collection of scholar articles, industry news, and interviews with the professionals accelerating innovation in skin health and patient care. This content is yet another way beyond our in-person and virtual events to strengthen the community of innovators we aim to build and maintain.

Jan 18, 2017
By: Advancing Innovation in Dermatology

Pemphigus Vulgaris: An interview with Masayuki Amagai, MD, PhD

Welcome to the sixth installment of Benchside Dispatches, a series of interviews with top researchers in the field of dermatology intended to highlight important advances in the care of medical skin disorders. Over the course of this series, prominent thought leaders will explore the burgeoning research in specific dermatologic disease states and how significant advancements in basic science are fueling a healthy pipeline of new candidate therapeutics.

In this installment, Masayuki Amagai, MD, PhD, discusses pemphigus vulgaris (PV). Dr. Amagai is Professor and Chair of the Department of Dermatology and Vice Dean at the Keio University School of Medicine. One of the world’s foremost researchers in PV and autoimmune blistering diseases, his work has been published in many high impact journals including Cell, the Journal of Clinical Investigation, Nature, and the New England Journal of Medicine. Dr. Amagai is an editor for numerous international dermatology journals, has received many of dermatology’s highest honors, and has served as president of the Japanese Society for Investigative Dermatology.

Read the full article: Download PDF